Skip to main content
Clinical Trials/KCT0005388
KCT0005388
Recruiting
未知

A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of AGE on Reducing Serum Uric Acid

H Plus Yangji Hospital0 sites56 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
H Plus Yangji Hospital
Enrollment
56
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
H Plus Yangji Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Subjects between 20 \~75 years of age 2\) Uric acid of
  • visit 1,2 is placed on 7\.0 mg/dL\~9\.0 mg/dL 3\) Subjects who agree the
  • particpation in the trial and submit informed and consent before the beginning
  • of the trial.

Exclusion Criteria

  • 1\) Those who have been diagnosed with gout (based on ACR /
  • EULAR: 2015\). 2\) Those who have experienced gouty seizure at least once. 3\)
  • Subjects who are receving treatment with severe cerebrovascular disease or
  • immune, respiratory sytem disease or disease of liver, kidney and urinary tract,
  • nervous system, or mental illness or malignant tumor. (If that patient's
  • clinical status is stable, they can participate in the clinical trial according
  • to investgator) 4\) Those who are hospitalized, medicated with Alcohol abuse and
  • dependence 5\) Those with history of urinary tract absences 6\) Those who have
  • taken uric acid inhibitors (allopurinol, phenytoestat etc.) 7\) Those taking
  • thiazide diuretics within 4 weeks of the start of the study 8\) Those who have

Outcomes

Primary Outcomes

Not specified

Similar Trials